Resultados de la reoperación en el síndrome de Zollinger-Ellison
La estrategia de los autores de este trabajo es reoperar a los pacientes con SZE con evidencia en los estudios por imágenes de recidiva del gastrinoma, si todos esos tumores pueden ser completamente resecados
Norton JA, Fraker DL, Alexander HR, et al. Surgery to cure the Zollinger- Ellison syndrome. N Engl J Med. 1999;341:635–644.
Norton JA, Alexander HA, Fraker DL, et al. Possible primary lymph node gastrinomas: occurrence, natural history and predictive factors: a prospective study. Ann Surg. 2003;237:650–659.
Norton JA, Fraker DL, Alexander HR, et al. Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndrome. Ann Surg. 2012;256:509–517.
Norton JA, Alexander HR, Fraker DL, et al. Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. Ann Surg. 2001;234:495–506.
Vinik AI, Anthony L, Boudreaux JP, et al. Neuroendocrine tumors: a critical appraisal of management strategies. Pancreas. 2010;39:801–818.
Maire F, Sauvanet A, Couvelard A, et al. Recurrence after surgical resection of gastrinoma: who, when, where, and why? Eur J Gastroenterol Hepatol. 2012;24:368–374.
Grobmyer SR, Hochwald SN. Reoperative surgery for the Zollinger- Ellison syndrome. Adv Surg. 2010;44:327–346.
Grobmyer SR, Vogel SB, McGuigan JE, et al. Reoperative surgery in sporadic Zollinger-Ellison Syndrome: long-term results. J Am Coll Surg. 2009;208:718–722.
Nishio K, Nishio A, Nishikawa T, et al. Recurrent gastrinoma in the mesentery 19 years after primary resection. Dig Dis Sci. 2007;52:3104–3108.
Jaskowiak NT, Fraker DL, Alexander HR, et al. Is reoperation for gastrinoma excision in Zollinger-Ellison syndrome (ZES) indicated? Surgery. 1996;120:1057–1063.
Collen MJ, Howard JM, McArthur KE, et al. Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion. Ann Intern Med. 1984;100:52–58.
Sheppard BC, Norton JA, Doppman JL, et al. Management of islet cell tumors in patients with Multiple Endocrine Neoplasia: a prospective study. Surgery. 1989;106:1108–1117.
Benya RV, Metz DC, Venzon DJ, et al. Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasiatype 1. Am J Med. 1994;97:436–444.
Krudy AG, Doppman JL, Jensen RT, et al. Localization of islet cell tumors by dynamic CT: comparison with plain CT, arteriography, sonography, and venous sampling. Am J Roentgenol. 1984;143:585–589.
Gibril F, Reynolds JC, Doppman JL, et al. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas: a prospective study. Ann Intern Med. 1996;125:26–34.
Norton JA, Krampitz G, Jensen RT. Multiple Endocrine Neoplasia: genetics and clinical management. Surg Oncol Clin N Am. 2015;24:795–832.
Doppman JL, Miller DL, Chang R, et al. Gastrinomas: localization by means of selective intraarterial injection of secretin. Radiology. 1990;174:25–29.
Cherner JA, Doppman JL, Norton JA, et al. Selective venous sampling for gastrin to localize gastrinomas. A prospective study. Ann Intern Med. 1986;105:841–847.
MacFarlane MP, Fraker DL, Alexander HR, et al. A prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia-Type 1. Surgery. 1995;118:973–980.
Norton JA, Doherty GD, Fraker DL, et al. Surgical treatment of localized gastrinoma within the liver: a prospective study. Surgery. 1998;124:1145– 1152.
Norton JA,Warren RS, Kelly MG, et al. Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery. 2003;134:1057–1065.
Fishbeyn VA, Norton JA, Benya RV, et al. Assessment and prediction of longterm cure in patients with Zollinger-Ellison syndrome: the best approach. Ann Intern Med. 1993;119:199–206.
Norton JA, Doppman JL, Jensen RT. Curative resection in Zollinger- Ellison syndrome: results of a 10-year prospective study. Ann Surg.